Katherine Rifiotis Slivensky

Associate

Chicago + 1.312.269.4124

Contacto:

Compartir

Katherine Slivensky focuses her practice on advising public companies and private equity funds on mergers and acquisitions and related corporate governance matters. Her practice includes domestic and cross-border transactions, as well as corporate restructurings. She also represents institutional investors in connection with primary and secondary investments.

Prior to attending law school, Katherine worked as a policy analyst at a Department of Energy nuclear physics laboratory and later joined the compliance team of a Fortune 500 financial services firm, where she focused on regulatory strategy and organizational risk management.

Experiencia

  • Riverside acquires OnvivJones Day advised The Riverside Company in the acquisition and financing by healthcare portfolio company Decera Clinical of Onviv, Inc., a healthcare and medical intelligence platform.
  • Adams Street Partners acquires portfolio of private equity fund interestsJones Day represented Adams Street Partners in the acquisition of a portfolio of private equity fund interests from a global investment management firm with an aggregate net asset value in excess of $400 million.
  • Nutrien completes $1 billion Senior Notes offeringJones Day represented Nutrien Ltd. in connection with a public offering of US$1 billion of Senior Notes, consisting of (i) US$500 million aggregate principal amount of 4.850% Senior Notes due 2031 and (ii) US$500 million aggregate principal amount of 5.350% Senior Notes due 2036.
  • BioMarin acquires Amicus Therapeutics for $4.8 billionJones Day advised BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) in its $4.8 billion acquisition of Amicus Therapeutics (Nasdaq: FOLD).
  • WESCO Distribution completes $1.5 billion Senior Notes offeringJones Day represented WESCO International, Inc., a leading provider of business-to-business distribution, logistics services and supply chain solutions, in connection with its $1.5 billion Rule 144A and Regulation S offering of Senior Notes, consisting of $650 million of 5.250% Senior Notes due 2031 and $850 million of 5.500% Senior Notes due 2034 by direct subsidiary of WESCO International, Inc.
  • U.S. Marine Corps veteran granted permanent and total disability ratingJones Day represented a U.S. Marine Corps veteran before the Department of Veterans Affairs through the Firm's Vetlex program.
    •

    April 2026 Podcast

    JONES DAY TALKS®: Perspectives and Pathways Conference Delivers Career Guidance to Top Law School Talent

    Antes del envío, por favor tenga en cuenta:

    la información contenida en www.jonesday.com es para uso general y no constituye asesoramiento legal. El envío y recepción de este correo electrónico no pretenden crear una relación abogado-cliente. La información que envíe a cualquier persona de nuestra Firma no tendrá carácter confidencial o privilegiado excepto en el caso de que estemos actúando en su representación. Si envía este correo electrónico, confirma que ha leído y comprendido este aviso.